 | • レポートコード：QYR9ST04915 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、カポジ肉腫の世界市場について調査・分析し、カポジ肉腫の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（クラシック、風土病、免疫抑制療法関連、流行病）、用途別（病院、癌研究機関、クリニック）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のカポジ肉腫市場動向 ・主要企業別マーケットシェア ・カポジ肉腫の種類別市場規模2014-2019 （クラシック、風土病、免疫抑制療法関連、流行病） ・カポジ肉腫の用途別市場規模2014-2019 （病院、癌研究機関、クリニック） ・カポジ肉腫の北米市場：主要企業・種類別/用途別市場規模 ・カポジ肉腫のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・カポジ肉腫の中国市場：主要企業・種類別/用途別市場規模 ・カポジ肉腫の日本国内市場：主要企業・種類別/用途別市場規模 ・カポジ肉腫の東南アジア市場：主要企業・種類別/用途別市場規模 ・カポジ肉腫のインド市場：主要企業・種類別/用途別市場規模 ・カポジ肉腫の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Aphios、Bristol Myers Squibb、Cytori Therapeutics、CytRx、Eli Lilly and Company、GlaxoSmithKline、Roche、Johnson and Johnson、Merck、Pfizer） ・カポジ肉腫の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Kaposi’s sarcoma (KS) is a type of cancer that can form masses in the skin, lymph nodes, or other organs. The skin lesions are usually purplein color. They can occur singularly, in a limited area, or be widespread. It may worsen either gradually or quickly. Lesions may be flat or raised.Four sub-types are described: classic, endemic, immunosuppresion therapy-related, and epidemic. Classic KS tends to affect older men, be slow growing, and affect the legs. Endemic KS occurs in young adult males in Africa and can be more aggressive. Immunosuppresion therapy-related KS generally occurs in people following organ transplantation and mostly affects the skin. Epidemic KS occurs in people with AIDS and many parts of the body can be affected. The diagnosis is by tissue biopsy while the extent of disease may be determined by medical imaging.
In 2018, the global Kaposi Sarcoma market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Kaposi Sarcoma status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Kaposi Sarcoma development in United States, Europe and China.
The key players covered in this study
Aphios
Bristol Myers Squibb
Cytori Therapeutics
CytRx
Eli Lilly and Company
GlaxoSmithKline
Roche
Johnson and Johnson
Merck
Pfizer
Market segment by Type, the product can be split into
Classic
Endemic
Immunosuppresion Therapy-Related
Epidemic
Market segment by Application, split into
Hospital
Cancer Research Institution
Clinics
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Kaposi Sarcoma status, future forecast, growth opportunity, key market and key players.
To present the Kaposi Sarcoma development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Kaposi Sarcoma are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Kaposi Sarcoma Market Size Growth Rate by Type (2014-2025)
1.4.2 Classic
1.4.3 Endemic
1.4.4 Immunosuppresion Therapy-Related
1.4.5 Epidemic
1.5 Market by Application
1.5.1 Global Kaposi Sarcoma Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Cancer Research Institution
1.5.4 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Kaposi Sarcoma Market Size
2.2 Kaposi Sarcoma Growth Trends by Regions
2.2.1 Kaposi Sarcoma Market Size by Regions (2014-2025)
2.2.2 Kaposi Sarcoma Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Kaposi Sarcoma Market Size by Manufacturers
3.1.1 Global Kaposi Sarcoma Revenue by Manufacturers (2014-2019)
3.1.2 Global Kaposi Sarcoma Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Kaposi Sarcoma Market Concentration Ratio (CR5 and HHI)
3.2 Kaposi Sarcoma Key Players Head office and Area Served
3.3 Key Players Kaposi Sarcoma Product/Solution/Service
3.4 Date of Enter into Kaposi Sarcoma Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Kaposi Sarcoma Market Size by Type (2014-2019)
4.2 Global Kaposi Sarcoma Market Size by Application (2014-2019)
5 United States
5.1 United States Kaposi Sarcoma Market Size (2014-2019)
5.2 Kaposi Sarcoma Key Players in United States
5.3 United States Kaposi Sarcoma Market Size by Type
5.4 United States Kaposi Sarcoma Market Size by Application
6 Europe
6.1 Europe Kaposi Sarcoma Market Size (2014-2019)
6.2 Kaposi Sarcoma Key Players in Europe
6.3 Europe Kaposi Sarcoma Market Size by Type
6.4 Europe Kaposi Sarcoma Market Size by Application
7 China
7.1 China Kaposi Sarcoma Market Size (2014-2019)
7.2 Kaposi Sarcoma Key Players in China
7.3 China Kaposi Sarcoma Market Size by Type
7.4 China Kaposi Sarcoma Market Size by Application
8 Japan
8.1 Japan Kaposi Sarcoma Market Size (2014-2019)
8.2 Kaposi Sarcoma Key Players in Japan
8.3 Japan Kaposi Sarcoma Market Size by Type
8.4 Japan Kaposi Sarcoma Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Kaposi Sarcoma Market Size (2014-2019)
9.2 Kaposi Sarcoma Key Players in Southeast Asia
9.3 Southeast Asia Kaposi Sarcoma Market Size by Type
9.4 Southeast Asia Kaposi Sarcoma Market Size by Application
10 India
10.1 India Kaposi Sarcoma Market Size (2014-2019)
10.2 Kaposi Sarcoma Key Players in India
10.3 India Kaposi Sarcoma Market Size by Type
10.4 India Kaposi Sarcoma Market Size by Application
11 Central & South America
11.1 Central & South America Kaposi Sarcoma Market Size (2014-2019)
11.2 Kaposi Sarcoma Key Players in Central & South America
11.3 Central & South America Kaposi Sarcoma Market Size by Type
11.4 Central & South America Kaposi Sarcoma Market Size by Application
12 International Players Profiles
12.1 Aphios
12.1.1 Aphios Company Details
12.1.2 Company Description and Business Overview
12.1.3 Kaposi Sarcoma Introduction
12.1.4 Aphios Revenue in Kaposi Sarcoma Business (2014-2019)
12.1.5 Aphios Recent Development
12.2 Bristol Myers Squibb
12.2.1 Bristol Myers Squibb Company Details
12.2.2 Company Description and Business Overview
12.2.3 Kaposi Sarcoma Introduction
12.2.4 Bristol Myers Squibb Revenue in Kaposi Sarcoma Business (2014-2019)
12.2.5 Bristol Myers Squibb Recent Development
12.3 Cytori Therapeutics
12.3.1 Cytori Therapeutics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Kaposi Sarcoma Introduction
12.3.4 Cytori Therapeutics Revenue in Kaposi Sarcoma Business (2014-2019)
12.3.5 Cytori Therapeutics Recent Development
12.4 CytRx
12.4.1 CytRx Company Details
12.4.2 Company Description and Business Overview
12.4.3 Kaposi Sarcoma Introduction
12.4.4 CytRx Revenue in Kaposi Sarcoma Business (2014-2019)
12.4.5 CytRx Recent Development
12.5 Eli Lilly and Company
12.5.1 Eli Lilly and Company Company Details
12.5.2 Company Description and Business Overview
12.5.3 Kaposi Sarcoma Introduction
12.5.4 Eli Lilly and Company Revenue in Kaposi Sarcoma Business (2014-2019)
12.5.5 Eli Lilly and Company Recent Development
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Company Details
12.6.2 Company Description and Business Overview
12.6.3 Kaposi Sarcoma Introduction
12.6.4 GlaxoSmithKline Revenue in Kaposi Sarcoma Business (2014-2019)
12.6.5 GlaxoSmithKline Recent Development
12.7 Roche
12.7.1 Roche Company Details
12.7.2 Company Description and Business Overview
12.7.3 Kaposi Sarcoma Introduction
12.7.4 Roche Revenue in Kaposi Sarcoma Business (2014-2019)
12.7.5 Roche Recent Development
12.8 Johnson and Johnson
12.8.1 Johnson and Johnson Company Details
12.8.2 Company Description and Business Overview
12.8.3 Kaposi Sarcoma Introduction
12.8.4 Johnson and Johnson Revenue in Kaposi Sarcoma Business (2014-2019)
12.8.5 Johnson and Johnson Recent Development
12.9 Merck
12.9.1 Merck Company Details
12.9.2 Company Description and Business Overview
12.9.3 Kaposi Sarcoma Introduction
12.9.4 Merck Revenue in Kaposi Sarcoma Business (2014-2019)
12.9.5 Merck Recent Development
12.10 Pfizer
12.10.1 Pfizer Company Details
12.10.2 Company Description and Business Overview
12.10.3 Kaposi Sarcoma Introduction
12.10.4 Pfizer Revenue in Kaposi Sarcoma Business (2014-2019)
12.10.5 Pfizer Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Kaposi Sarcoma Key Market Segments
Table Key Players Kaposi Sarcoma Covered
Table Global Kaposi Sarcoma Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Kaposi Sarcoma Market Size Market Share by Type 2014-2025
Figure Classic Figures
Table Key Players of Classic
Figure Endemic Figures
Table Key Players of Endemic
Figure Immunosuppresion Therapy-Related Figures
Table Key Players of Immunosuppresion Therapy-Related
Figure Epidemic Figures
Table Key Players of Epidemic
Table Global Kaposi Sarcoma Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Cancer Research Institution Case Studies
Figure Clinics Case Studies
Figure Kaposi Sarcoma Report Years Considered
Table Global Kaposi Sarcoma Market Size 2014-2025 (Million US$)
Figure Global Kaposi Sarcoma Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Kaposi Sarcoma Market Size by Regions 2014-2025 (Million US$)
Table Global Kaposi Sarcoma Market Size by Regions 2014-2019 (Million US$)
Table Global Kaposi Sarcoma Market Share by Regions 2014-2019
Figure Global Kaposi Sarcoma Market Share by Regions 2014-2019
Figure Global Kaposi Sarcoma Market Share by Regions 2019
Table Market Top Trends
Table Global Kaposi Sarcoma Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Kaposi Sarcoma Market Share by Manufacturers (2014-2019)
Figure Global Kaposi Sarcoma Market Share by Manufacturers in 2018
Table Global Kaposi Sarcoma Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Kaposi Sarcoma Product/Solution/Service
Table Date of Enter into Kaposi Sarcoma Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Kaposi Sarcoma Market Size by Type (2014-2019) (Million US$)
Table Global Kaposi Sarcoma Market Size Share by Type (2014-2019)
Figure Global Kaposi Sarcoma Market Size Market Share by Type (2014-2019)
Table Global Kaposi Sarcoma Market Size by Application (2014-2019) (Million US$)
Table Global Kaposi Sarcoma Market Size Share by Application (2014-2019)
Figure Global Kaposi Sarcoma Market Size Market Share by Application (2014-2019)
Figure Global Kaposi Sarcoma Revenue Market Share by Application in 2018
Figure United States Kaposi Sarcoma Market Size 2014-2019 (Million US$)
Table United States Key Players Kaposi Sarcoma Revenue (2018-2019) (Million US$)
Table United States Key Players Kaposi Sarcoma Market Share (2018-2019)
Table United States Kaposi Sarcoma Market Size by Type (2014-2019) (Million US$)
Table United States Kaposi Sarcoma Market Share by Type (2014-2019)
Table United States Kaposi Sarcoma Market Size by Application (2014-2019) (Million US$)
Table United States Kaposi Sarcoma Market Share by Application (2014-2019)
Figure Europe Kaposi Sarcoma Market Size 2014-2019 (Million US$)
Table Europe Key Players Kaposi Sarcoma Revenue (2018-2019) (Million US$)
Table Europe Key Players Kaposi Sarcoma Market Share (2018-2019)
Table Europe Kaposi Sarcoma Market Size by Type (2014-2019) (Million US$)
Table Europe Kaposi Sarcoma Market Share by Type (2014-2019)
Table Europe Kaposi Sarcoma Market Size by Application (2014-2019) (Million US$)
Table Europe Kaposi Sarcoma Market Share by Application (2014-2019)
Figure China Kaposi Sarcoma Market Size 2014-2019 (Million US$)
Table China Key Players Kaposi Sarcoma Revenue (2018-2019) (Million US$)
Table China Key Players Kaposi Sarcoma Market Share (2018-2019)
Table China Kaposi Sarcoma Market Size by Type (2014-20189) (Million US$)
Table China Kaposi Sarcoma Market Share by Type (2014-2019)
Table China Kaposi Sarcoma Market Size by Application (2014-2019) (Million US$)
Table China Kaposi Sarcoma Market Share by Application (2014-2019)
Figure Japan Kaposi Sarcoma Market Size 2014-2019 (Million US$)
Table Japan Key Players Kaposi Sarcoma Revenue (2018-2019) (Million US$)
Table Japan Key Players Kaposi Sarcoma Market Share (2018-2019)
Table Japan Kaposi Sarcoma Market Size by Type (2014-2019) (Million US$)
Table Japan Kaposi Sarcoma Market Share by Type (2014-2019)
Table Japan Kaposi Sarcoma Market Size by Application (2014-2019) (Million US$)
Table Japan Kaposi Sarcoma Market Share by Application (2014-2019)
Figure Southeast Asia Kaposi Sarcoma Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Kaposi Sarcoma Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Kaposi Sarcoma Market Share (2018-2019)
Table Southeast Asia Kaposi Sarcoma Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Kaposi Sarcoma Market Share by Type (2014-2019)
Table Southeast Asia Kaposi Sarcoma Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Kaposi Sarcoma Market Share by Application (2014-2019)
Figure India Kaposi Sarcoma Market Size 2014-2019 (Million US$)
Table India Key Players Kaposi Sarcoma Revenue (2018-2019) (Million US$)
Table India Key Players Kaposi Sarcoma Market Share (2018-2019)
Table India Kaposi Sarcoma Market Size by Type (2014-2019) (Million US$)
Table India Kaposi Sarcoma Market Share by Type (2014-2019)
Table India Kaposi Sarcoma Market Size by Application (2014-2019) (Million US$)
Table India Kaposi Sarcoma Market Share by Application (2014-2019)
Figure Central & South America Kaposi Sarcoma Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Kaposi Sarcoma Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Kaposi Sarcoma Market Share (2018-2019)
Table Central & South America Kaposi Sarcoma Market Size by Type (2014-2019) (Million US$)
Table Central & South America Kaposi Sarcoma Market Share by Type (2014-2019)
Table Central & South America Kaposi Sarcoma Market Size by Application (2014-2019) (Million US$)
Table Central & South America Kaposi Sarcoma Market Share by Application (2014-2019)
Table Aphios Company Details
Table Aphios Revenue in Kaposi Sarcoma Business (2014-2019) (Million US$)
Figure Aphios Revenue Growth Rate in Kaposi Sarcoma Business (2014-2019)
Table Aphios Recent Development
Table Bristol Myers Squibb Company Details
Table Bristol Myers Squibb Revenue in Kaposi Sarcoma Business (2014-2019)(Million US$)
Figure Bristol Myers Squibb Revenue Growth Rate in Kaposi Sarcoma Business (2014-2019)
Table Bristol Myers Squibb Recent Development
Table Cytori Therapeutics Company Details
Table Cytori Therapeutics Revenue in Kaposi Sarcoma Business (2014-2019)(Million US$)
Figure Cytori Therapeutics Revenue Growth Rate in Kaposi Sarcoma Business (2014-2019)
Table Cytori Therapeutics Recent Development
Table CytRx Company Details
Table CytRx Revenue in Kaposi Sarcoma Business (2014-2019)(Million US$)
Figure CytRx Revenue Growth Rate in Kaposi Sarcoma Business (2014-2019)
Table CytRx Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Kaposi Sarcoma Business (2014-2019)(Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Kaposi Sarcoma Business (2014-2019)
Table Eli Lilly and Company Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Kaposi Sarcoma Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Kaposi Sarcoma Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Roche Company Details
Table Roche Revenue in Kaposi Sarcoma Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Kaposi Sarcoma Business (2014-2019)
Table Roche Recent Development
Table Johnson and Johnson Company Details
Table Johnson and Johnson Revenue in Kaposi Sarcoma Business (2014-2019)(Million US$)
Figure Johnson and Johnson Revenue Growth Rate in Kaposi Sarcoma Business (2014-2019)
Table Johnson and Johnson Recent Development
Table Merck Company Details
Table Merck Revenue in Kaposi Sarcoma Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Kaposi Sarcoma Business (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Kaposi Sarcoma Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Kaposi Sarcoma Business (2014-2019)
Table Pfizer Recent Development
Table Global Kaposi Sarcoma Market Size by Regions (Million US$) 2019-2025
Figure Global Kaposi Sarcoma Market Size Share by Regions (2019-2025)
Figure Global Kaposi Sarcoma Market Size Share by Regions in 2025
Figure United States Kaposi Sarcoma Market Size Forecast (2019-2025)(Million USD)
Figure Europe Kaposi Sarcoma Market Size Forecast (2019-2025)(Million USD)
Figure China Kaposi Sarcoma Market Size Forecast (2019-2025)(Million USD)
Figure Japan Kaposi Sarcoma Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Kaposi Sarcoma Market Size Forecast (2019-2025)(Million USD)
Figure India Kaposi Sarcoma Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Kaposi Sarcoma Market Size Forecast (2019-2025)(Million USD)
Table Global Kaposi Sarcoma Market Size by Product (2019-2025) (Million US$)
Figure Global Kaposi Sarcoma Market Size by Product (2019-2025)
Figure Global Kaposi Sarcoma Market Size by Product in 2025
Table Global Kaposi Sarcoma Market Size by Application (2019-2025) (Million US$)
Figure Global Kaposi Sarcoma Market Size by Application (2019-2025)
Figure Global Kaposi Sarcoma Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
エイズ関連癌の世界市場：市場規模・現状・予測 The cancers occurring most commonly in the patients infected with human immunodeficiency virus (HIV) are referred to as AIDS related cancers. Kaposi sarcoma, cervical cancer and non-Hodgkin lymphoma are some of the most common AIDS related cancers. Cancers of throat, lungs, colon, skin, rectum, mout…- エイズ関連癌の世界市場：市場規模・現状・予測 The cancers occurring most commonly in the patients infected with human immunodeficiency virus (HIV) are referred to as AIDS related cancers. Kaposi sarcoma, cervical cancer and non-Hodgkin lymphoma are some of the most common AIDS related cancers. Cancers of throat, lungs, colon, skin, rectum, mout…
- 加齢黄斑変性症遺伝子治療の世界市場：市場規模・現状・予測 Macular degeneration is a condition in which, macula, a part of the retina, gets damaged or deteriorated. This condition usually affects individuals who are aged 50 years and above and therefore, it is called age-related macular degeneration (AMD). AMD is the leading cause of vision loss and is dire…
- 糖尿病及び関連疾患向け幹細胞療法の世界市場：市場規模・現状・予測 Diabetes is the metabolic disorder that is associated with the glucose level in the blood. It is mainly divided into two types, insulin-dependent diabetes mellitus or juvenile onset (type 1) and non-insulin-dependent diabetes mellitus, or adult-onset diabetes (type 2).NSI-566 is the stem cell therap…
- 糖尿病及び関連疾患向け幹細胞療法の世界市場：市場規模・現状・予測 Diabetes is the metabolic disorder that is associated with the glucose level in the blood. It is mainly divided into two types, insulin-dependent diabetes mellitus or juvenile onset (type 1) and non-insulin-dependent diabetes mellitus, or adult-onset diabetes (type 2).NSI-566 is the stem cell therap…